Price T Rowe Associates Inc. MD Increases Stock Holdings in Nano-X Imaging Ltd. (NASDAQ:NNOX)

Price T Rowe Associates Inc. MD lifted its position in Nano-X Imaging Ltd. (NASDAQ:NNOX) by 26.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,990 shares of the company’s stock after buying an additional 4,658 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Nano-X Imaging were worth $159,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC lifted its holdings in shares of Nano-X Imaging by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 688,512 shares of the company’s stock worth $4,957,000 after buying an additional 10,659 shares in the last quarter. ARK Investment Management LLC lifted its position in Nano-X Imaging by 19.0% during the fourth quarter. ARK Investment Management LLC now owns 300,757 shares of the company’s stock valued at $2,165,000 after purchasing an additional 48,124 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Nano-X Imaging by 4.6% during the fourth quarter. Bank of New York Mellon Corp now owns 146,551 shares of the company’s stock valued at $1,055,000 after purchasing an additional 6,449 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Nano-X Imaging by 3.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 132,298 shares of the company’s stock valued at $953,000 after purchasing an additional 5,017 shares during the last quarter. Finally, Barclays PLC lifted its position in Nano-X Imaging by 16.0% during the fourth quarter. Barclays PLC now owns 99,929 shares of the company’s stock valued at $719,000 after purchasing an additional 13,748 shares during the last quarter. 21.49% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on NNOX shares. D. Boral Capital reiterated a “buy” rating and set a $15.00 target price on shares of Nano-X Imaging in a research report on Thursday, April 17th. Cantor Fitzgerald dropped their target price on shares of Nano-X Imaging from $12.00 to $9.00 and set an “overweight” rating for the company in a research report on Tuesday, April 1st.

Nano-X Imaging Price Performance

Shares of Nano-X Imaging stock opened at $5.60 on Friday. Nano-X Imaging Ltd. has a 1 year low of $3.75 and a 1 year high of $11.00. The firm has a market cap of $323.56 million, a PE ratio of -6.59 and a beta of 2.03. The company has a 50 day simple moving average of $5.14 and a two-hundred day simple moving average of $6.36.

Nano-X Imaging (NASDAQ:NNOX) last posted its quarterly earnings results on Monday, March 31st. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). The business had revenue of $3.00 million for the quarter, compared to analysts’ expectations of $3.80 million. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. As a group, research analysts anticipate that Nano-X Imaging Ltd. will post -0.92 earnings per share for the current year.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.